PHILADELPHIA (PRWEB)
June 05, 2023

Biomeme, a leader in molecular diagnostics, has been honored with a prestigious award at the 2023 PACT Enterprise Awards. The event celebrated technological innovation in technology, life sciences, and investment, recognizing Biomeme’s outstanding contributions.

“We are honored to receive this prestigious award,” said Max Perelman, CEO at Biomeme. In 2012, Marc DeJohn, Jesse vanWestrienen and I started Biomeme. In a decade, we went from our first prototype PCR thermocycler using a travel hair dryer and an iPhone 4 to being one of the nation’s leading biotechnology companies offering streamlined solutions for molecular detection. I would like to say thank you to everyone within the Biomeme family who have made it possible for us to have achieved so much these past 10 years. And I look forward to working with all of you on this next leg of our adventure.”

Biomeme’s state-of-the-art testing solution includes hardware, software, pathogen diagnostics and Host Response-based diagnostic tests which are engineered to handle complex genetic analysis in a user friendly, small form factor and fully mobile fashion without compromising accuracy or sensitivity. Not only do Biomeme’s solutions bring many compelling aspects to biowarfare agent detection, as evidenced by its use within the U.S. Special Operations Forces, but Biomeme is a leader in the next generation diagnostic framework called Host Response. Host Response-based diagnostics read the telltale signs of your body, the Host, as it fights an infection. Host Response involves measuring the expressions of thousands of genes, then using advanced machine learning to identify patterns (called signatures), and then translating these patterns into a quantitative molecular diagnostic assay. Our first Host Response-based diagnostic empowers clinicians with the knowledge of whether an illness is due to a bacterial or viral infection, enabling them to make more informed decisions about prescribing antibiotics. This diagnostic will be a key tool for guiding clinical decision-making and for health systems to further develop their antibiotic stewardship programs in the fight against antimicrobial resistance.

“Every year, the list of finalists and winners continues to impress and inspire all of us at PACT,” said Dianne Strunk, Vice President, PACT.” The Enterprise Awards celebrates Philadelphia’s technology and life sciences ecosystem, bringing together a diverse group of individuals and organizations solving some of the world’s most complex challenges. On behalf of my PACT colleagues, I offer sincere congratulations to Biomeme, Inc. for being recognized as the Life Sciences & Healthcare Emerging at the 2023 PACT Enterprise Awards.”

About Biomeme, Inc.

Biomeme is a leading provider of molecular diagnostic solutions, focused on revolutionizing disease detection and real-time surveillance. Biomeme was founded with the simple premise of empowering anyone, anywhere, with the capabilities to understand the biological world. Our groundbreaking mobile molecular testing platform has offered our users elegant solutions to highly complex problems. And we’re leveraging our expert knowledge of Earth’s smallest life forms to address Earth’s biggest health challenges. http://www.biomeme.com

About Philadelphia Alliance for Capital and Technologies (PACT)

PACT’s vision is to be the go-to resource for fast growing companies, and a driver of entrepreneurship and innovation in the Philadelphia region. PACT provides its members with valuable content and connections to capital, coaching, and customers that will accelerate their growth and success, and to collaborate with other organizations to drive innovation and entrepreneurship in the region. http://www.philadelphiapact.com

Link: https://philadelphiapact.com/2023-enterprise-awards-winners/

For media inquiries, please contact:

Tom Cook

267-930-7707

tom.cook@biomeme.com

Share article on social media or email: